These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36677547)

  • 1. Isomeric Activity Cliffs-A Case Study for Fluorine Substitution of Aminergic G Protein-Coupled Receptor Ligands.
    Pietruś W; Kurczab R; Warszycki D; Bojarski AJ; Bajorath J
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data-Driven Analysis of Fluorination of Ligands of Aminergic G Protein Coupled Receptors.
    Pietruś W; Kurczab R; Stumpfe D; Bojarski AJ; Bajorath J
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
    Khan AM; Shawon J; Halim MA
    J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning the Biological Activity of PI3K
    Pietruś W; Stypik M; Zagozda M; Banach M; Gurba-Bryśkiewicz L; Maruszak W; Leniak A; Kurczab R; Ochal Z; Dubiel K; Wieczorek M
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.
    Urmi KF; Finch AM; Griffith R
    J Mol Graph Model; 2017 Sep; 76():488-503. PubMed ID: 28818718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Consensus Scoring Scheme for Selecting Class A Aminergic GPCR Fragments.
    Kelemen ÁA; Kiss R; Ferenczy GG; Kovács L; Flachner B; Lőrincz Z; Keserű GM
    J Chem Inf Model; 2016 Feb; 56(2):412-22. PubMed ID: 26760056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards predictive docking at aminergic G-protein coupled receptors.
    Jakubík J; El-Fakahany EE; Doležal V
    J Mol Model; 2015 Nov; 21(11):284. PubMed ID: 26453085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases.
    Hardianto A; Yusuf M; Liu F; Ranganathan S
    BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
    J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the performance of MM/PBSA for binding affinity prediction using class A GPCR crystal structures.
    Yau MQ; Emtage AL; Chan NJY; Doughty SW; Loo JSE
    J Comput Aided Mol Des; 2019 May; 33(5):487-496. PubMed ID: 30989574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations.
    Katari SK; Natarajan P; Swargam S; Kanipakam H; Pasala C; Umamaheswari A
    J Recept Signal Transduct Res; 2016 Dec; 36(6):558-571. PubMed ID: 26906522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.